PAREXEL Closes $750M Unsecured Loan

PAREXEL Closes $750M Unsecured Loan

Firm News

WilmerHale represented PAREXEL International Corporation—a leading global biopharmaceutical services organization—in a $750 million unsecured term loan and revolving credit facility, which closed on March 11, 2016.  The loan facility will be made available to PAREXEL International Corporation as well as its Dutch and Irish subsidiaries.
 
The WilmerHale team for this transaction was led by Partner John Sigel, Special Counsel Jamie Class and Senior Associate Ellie Guadiana.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.